AKANDA CORP (AKAN) Fundamental Analysis & Valuation

NASDAQ:AKAN • CA00971M6018

Current stock price

0.785 USD
-0.02 (-2.11%)
At close:
0.8321 USD
+0.05 (+6%)
After Hours:

This AKAN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. AKAN Profitability Analysis

1.1 Basic Checks

  • In the past year AKAN has reported negative net income.
  • In the past year AKAN has reported a negative cash flow from operations.
  • In the past 5 years AKAN always reported negative net income.
  • AKAN had a negative operating cash flow in each of the past 5 years.
AKAN Yearly Net Income VS EBIT VS OCF VS FCFAKAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

  • AKAN's Return On Assets of -51.76% is on the low side compared to the rest of the industry. AKAN is outperformed by 64.58% of its industry peers.
  • Looking at the Return On Equity, with a value of -95.78%, AKAN is doing worse than 63.54% of the companies in the same industry.
Industry RankSector Rank
ROA -51.76%
ROE -95.78%
ROIC N/A
ROA(3y)-148.92%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AKAN Yearly ROA, ROE, ROICAKAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K

1.3 Margins

  • AKAN has a Gross Margin (24.91%) which is comparable to the rest of the industry.
  • The Profit Margin and Operating Margin are not available for AKAN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AKAN Yearly Profit, Operating, Gross MarginsAKAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. AKAN Health Analysis

2.1 Basic Checks

  • AKAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, AKAN has more shares outstanding
  • The debt/assets ratio for AKAN has been reduced compared to a year ago.
AKAN Yearly Shares OutstandingAKAN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20K 40K 60K
AKAN Yearly Total Debt VS Total AssetsAKAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • AKAN has an Altman-Z score of -11.41. This is a bad value and indicates that AKAN is not financially healthy and even has some risk of bankruptcy.
  • AKAN has a Altman-Z score of -11.41. This is in the lower half of the industry: AKAN underperforms 73.96% of its industry peers.
  • A Debt/Equity ratio of 0.08 indicates that AKAN is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.08, AKAN perfoms like the industry average, outperforming 52.08% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z -11.41
ROIC/WACCN/A
WACC8.49%
AKAN Yearly LT Debt VS Equity VS FCFAKAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

  • AKAN has a Current Ratio of 1.39. This is a normal value and indicates that AKAN is financially healthy and should not expect problems in meeting its short term obligations.
  • AKAN's Current ratio of 1.39 is on the low side compared to the rest of the industry. AKAN is outperformed by 72.40% of its industry peers.
  • A Quick Ratio of 1.39 indicates that AKAN should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.39, AKAN is not doing good in the industry: 65.10% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 1.39
AKAN Yearly Current Assets VS Current LiabilitesAKAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. AKAN Growth Analysis

3.1 Past

  • AKAN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 99.32%, which is quite impressive.
  • The Revenue for AKAN has decreased by -61.27% in the past year. This is quite bad
  • Measured over the past years, AKAN shows a very strong growth in Revenue. The Revenue has been growing by 172.39% on average per year.
EPS 1Y (TTM)99.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.32%
Revenue 1Y (TTM)-61.27%
Revenue growth 3Y172.39%
Revenue growth 5YN/A
Sales Q2Q%97.47%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AKAN Yearly Revenue VS EstimatesAKAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

Find the best growth stocksShow best growing peers

0

4. AKAN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AKAN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AKAN Price Earnings VS Forward Price EarningsAKAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AKAN Per share dataAKAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AKAN Dividend Analysis

5.1 Amount

  • AKAN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AKAN Fundamentals: All Metrics, Ratios and Statistics

AKANDA CORP

NASDAQ:AKAN (3/18/2026, 8:00:00 PM)

After market: 0.8321 +0.05 (+6%)

0.785

-0.02 (-2.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-01
Earnings (Next)12-13
Inst Owners1.96%
Inst Owner Change-96.97%
Ins OwnersN/A
Ins Owner Change270.83%
Market Cap1.58M
Revenue(TTM)836.70K
Net Income(TTM)-4.10M
AnalystsN/A
Price TargetN/A
Short Float %1.25%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.89
P/FCF N/A
P/OCF N/A
P/B 0.37
P/tB 0.37
EV/EBITDA N/A
EPS(TTM)-61.41
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-3.02
FCFYN/A
OCF(TTM)-1.98
OCFYN/A
SpS0.42
BVpS2.13
TBVpS2.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -51.76%
ROE -95.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.91%
FCFM N/A
ROA(3y)-148.92%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1486.96%
Cap/Sales 250.76%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 1.39
Altman-Z -11.41
F-Score5
WACC8.49%
ROIC/WACCN/A
Cap/Depr(3y)505.52%
Cap/Depr(5y)N/A
Cap/Sales(3y)97.76%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.32%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-61.27%
Revenue growth 3Y172.39%
Revenue growth 5YN/A
Sales Q2Q%97.47%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y55.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-304.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-165.25%
OCF growth 3YN/A
OCF growth 5YN/A

AKANDA CORP / AKAN Fundamental Analysis FAQ

What is the fundamental rating for AKAN stock?

ChartMill assigns a fundamental rating of 1 / 10 to AKAN.


What is the valuation status of AKANDA CORP (AKAN) stock?

ChartMill assigns a valuation rating of 0 / 10 to AKANDA CORP (AKAN). This can be considered as Overvalued.


How profitable is AKANDA CORP (AKAN) stock?

AKANDA CORP (AKAN) has a profitability rating of 0 / 10.


Can you provide the financial health for AKAN stock?

The financial health rating of AKANDA CORP (AKAN) is 2 / 10.